Pyxis Oncology, Inc.
PYXS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782223
In the last 90 days, Pyxis Oncology, Inc. insiders filed 0 open-market purchases and 1 sale; 76 institutions reported holding it in 13F filings for Q2 2026, worth $101.1M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Pyxis Oncology, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −7 vs. Q3 2022
- Shares held
- 19.8M
- +317.8K (+1.6%) vs. Q3 2022
- Total value
- $26.5M
- −$11.8M (−30.9%) vs. Q3 2022
- New holders
- 2
- 13 more added
- Sold out
- 9
- 6 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PYXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 76 | $101.1M |
| Q1 2026 | 78 | $40.5M |
| Q4 2025 | 79 | $34.7M |
| Q3 2025 | 73 | $59.7M |
| Q2 2025 | 74 | $30.2M |
| Q1 2025 | 89 | $29.6M |
| Q4 2024 | 99 | $49.2M |
| Q3 2024 | 92 | $102.3M |
| Q2 2024 | 80 | $93.1M |
| Q1 2024 | 71 | $97.7M |
| Q4 2023 | 51 | $15.8M |
| Q3 2023 | 54 | $15.4M |
| Q2 2023 | 48 | $24.6M |
| Q1 2023 | 47 | $41.5M |
| Q4 2022 | 31 | $26.5M |
| Q3 2022 | 38 | $38.3M |
| Q2 2022 | 39 | $47.7M |
| Q1 2022 | 45 | $76.1M |
| Q4 2021 | 51 | $199.9M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Pyxis Oncology, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 3,470,700 | $4.65M | 0.68% | +2,059,131+145.9% | Added |
| Laurion Capital Management LP | 3,170,803 | $4.25M | 0.12% | 00.0% | Unchanged |
| BVF Inc | 2,938,851 | $3.94M | 0.17% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,562,798 | $2.09M | 0.00% | +32,013+2.1% | Added |
| Newtyn Management, LLC | 1,500,000 | $2.01M | 0.41% | +700,000+87.5% | Added |
| Barclays PLC | 948,051 | $1.27M | 0.00% | +4000.0% | Added |
| Vanguard Group Inc | 917,827 | $1.23M | 0.00% | +4430.0% | Added |
| OrbiMed Advisors LLC | 848,252 | $1.14M | 0.02% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 764,406 | $1.02M | 0.02% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 708,303 | $949.1K | 0.04% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 669,158 | $896.7K | 0.55% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 668,854 | $896.0K | 0.06% | −10.0% | Reduced |
| Citigroup Inc | 357,537 | $479.1K | 0.00% | +45,229+14.5% | Added |
| BlackRock Inc. | 211,332 | $283.2K | 0.00% | +4,778+2.3% | Added |
| Geode Capital Management, LLC | 203,934 | $273.0K | 0.00% | +15,113+8.0% | Added |
| Bridgeway Capital Management, LLC | 170,295 | $228.2K | 0.01% | +50,000+41.6% | Added |
| Morgan Stanley | 106,419 | $142.6K | 0.00% | −15,581−12.8% | Reduced |
| Renaissance Technologies LLC | 83,600 | $112.0K | 0.00% | −45,202−35.1% | Reduced |
| Acadian Asset Management LLC | 71,702 | $95.0K | 0.00% | +47,859+200.7% | Added |
| Bank of America Corp | 63,595 | $85.2K | 0.00% | +43,510+216.6% | Added |
| State Street Corp | 62,289 | $83.5K | 0.00% | +31,300+101.0% | Added |
| Marquette Asset Management, LLC | 58,862 | $78.9K | 0.02% | +58,862 | New |
| University of Chicago | 48,731 | $65.3K | 0.05% | +48,731 | New |
| Two Sigma Investments, LP | 35,477 | $47.5K | 0.00% | −2,200−5.8% | Reduced |
| Millennium Management LLC | 31,334 | $42.0K | 0.00% | −58,504−65.1% | Reduced |
| Northern Trust Corp | 26,398 | $35.4K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 25,000 | $33.5K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 17,739 | $23.8K | 0.00% | 00.0% | Unchanged |
| Tudor Investment Corp Et Al | 13,624 | $18.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,178 | $8.00K | 0.00% | −9,558−60.7% | Reduced |
| Wells Fargo & Company | 160 | $214 | 0.00% | +14+9.6% | Added |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −1,528,812−100.0% | Sold out |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −764,653−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −220,434−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −152,018−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −11,052−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −10,400−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −855−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −192−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −155−100.0% | Sold out |